fda approval tirzepatide vs. Semaglutide: What You Should Know RxConnection | FDA Approves New
Description
The results were consistent, and the safety profile looked similar to other GLP-1 drugs
No randomised trial has directly compared the renal effects of SGLT2i with those of GLP-1RA, nor is any such trial planned
Incorporate electrolytes : Use an electrolyte drink during long runs or intense training sessions
Depressive disorders: systematic review of approved
Semaglutide currently has the strongest evidence for hard cardiovascular outcomes among GLP-1 class compounds
This is not a market full of patients starting from scratch
